Phagos Raises €25m to End Bacterial Disease.
Read article
Phagos Raises €25m to End Bacterial Disease.
Read article
The sustainable alternative to antibiotics
The sustainable alternative to antibiotics
Microbiology meets AI to bring phage therapy into the modern era
Microbiology meets AI to bring phage therapy into the modern era
BACKED BY
BACKED BY
problem
problem
Bacterial disease is the 2nd leading cause of death worldwide
Bacterial disease is the 2nd leading cause of death worldwide
Bacterial infections can turn deadly, fast. To make it worse, many antibiotics are no longer effective due to antimicrobial resistance (AMR). New solutions are needed now in this urgent global health crisis.
Bacterial infections can turn deadly, fast. To make it worse, many antibiotics are no longer effective due to antimicrobial resistance (AMR). New solutions are needed now in this urgent global health crisis.



BACTERIA
BACTERIA

BACTERIA

BACTERIA
SOLUTION
SOLUTION
What are phages?
What are phages?
Bacteriophages, or phages, are the natural biological predators of bacteria. Through millions of years of evolution, phages have become so specialized that they can only detect and target highly specific bacteria, leaving all other cells untouched.
By finding the right phages from the environment, we can design antibacterial medicines, a process known as phage therapy.
Bacteriophages, or phages, are the natural biological predators of bacteria. Through millions of years of evolution, phages have become so specialized that they can only detect and target highly specific bacteria, leaving all other cells untouched.
By finding the right phages from the environment, we can design antibacterial medicines, a process known as phage therapy.
Learn more
Learn more



BACTERIOPHAGE
OUR PLATFORM
Alphagos is the world's first
AI-native phage therapy platform
The Alphagos platform combines our expertise in microbiology and AI to design ultra targeted bacterial treatments using phages. Treatments are continuously updated to fight against antimicrobial resistance (AMR).
Our solution is being deployed across chicken, cattle, swine, and shrimp sectors.
Explore the platform
Explore the platform

Our mission is to end bacterial disease
What if we could prevent the millions of projected deaths from antibiotic resistance? That’s what we’re working towards at Phagos. We’re taking a tech-first approach to unlock the therapeutic potential of phages to fight antimicrobial resistance.
Learn more

Our mission is to end bacterial disease
What if we could prevent the millions of projected deaths from antibiotic resistance? That’s what we’re working towards at Phagos. We’re taking a tech-first approach to unlock the therapeutic potential of phages to fight antimicrobial resistance.
Learn more











